ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 657270 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 657270; 2) Community: the network communities that were significantly associated with the response to NSC 657270; 3) Molecule: the relationships between components within communities and NSC 657270; 4) MDR: the compounds that were significantly associated with the NSC 657270.

NSC Compound Enrichment Correlation
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0220039422291536 0.25026719
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0220039422291536 0.28732819
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0220039422291536 0.25322777
NSC 733504 Everolimus 0.0220039422291536 -0.19435855
NSC 736041 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne 0.0220039422291536 0.20765551
NSC 737231 Null 0.0220039422291536 0.20354162
NSC 744063 Null 0.0220039422291536 0.2325209
NSC 87868 2-Phenylethyl isothiocyanate 0.0220039422291536 0.26176328
NSC 104942 EUPAROTIN 0.0220039422291538 0.4048718
NSC 119875 Cisplatin 0.0220039422291538 0.029914559
Total:116  Current:64    [First] [Prev] [Next] [Last]